MIST vs ZBH · rev $797.0K vs P/E 23, rev $4.26B
Milestone Pharmaceuticals Inc (MIST) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
MIST currently screens at market cap $160.6M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the MIST and ZBH stock pages for the full models.
Not investment advice.